Ophthalmic Viscoelastic Devices (OVD) Market Set for Steady Growth Driven by Rising Eye Surgeries

The Ophthalmic Viscoelastic Devices (OVD) Market is witnessing sustained growth, driven by the increasing prevalence of cataracts, glaucoma, corneal disorders, and the rising demand for advanced eye surgeries globally. OVDs are critical in ophthalmic procedures, providing surgeons with precision, safety, and enhanced outcomes by maintaining intraocular space, protecting corneal endothelium, and facilitating the implantation of intraocular lenses.

Technological advancements in viscoelastic formulations, including cohesive and dispersive OVDs, have expanded their applications across cataract, glaucoma, corneal, and vitreoretinal surgeries. Rising geriatric populations, growing awareness about eye health, and the increasing number of outpatient ophthalmic clinics are further fueling demand for these specialized devices. Additionally, the adoption of minimally invasive surgical techniques and the integration of OVDs with modern phacoemulsification systems are boosting market penetration across developed and emerging regions.

Market Overview

The global ophthalmic viscoelastic devices market was valued at USD 2964.59 Million in 2025. The industry is projected to grow at a CAGR of 4.10% during 2026–2035, reaching USD 4430.70 Million by 2035.

Key growth drivers include:

  • Increasing incidence of cataracts, glaucoma, and other ophthalmic disorders

  • Expansion of ophthalmic surgical centers and outpatient clinics

  • Rising preference for minimally invasive eye surgeries and advanced phacoemulsification techniques

  • Growing geriatric population requiring vision correction and surgical intervention

  • Technological innovations in OVD formulations for improved safety and surgical precision

The market is characterized by diverse product offerings, widespread applications in ophthalmology, and a global reach across hospitals, clinics, and specialized eye care centers.

Market Breakup by Product

Cohesive Ophthalmic Viscoelastic

Cohesive OVDs are primarily used for maintaining anterior chamber depth during cataract surgery. They are easy to remove, providing efficient space maintenance and tissue protection. These products are favored for procedures requiring rapid removal after implantation.

Dispersive Ophthalmic Viscoelastic

Dispersive OVDs excel in coating and protecting delicate tissues such as the corneal endothelium. They are widely used in complex surgeries, including glaucoma and vitreoretinal procedures, due to their ability to remain in the anterior chamber longer, reducing surgical risks.

Market Breakup by Applications

Cataract Surgery

Cataract procedures represent the largest segment of the OVD market, given the high prevalence of age-related cataracts. OVDs are essential for lens implantation, maintaining intraocular pressure, and ensuring tissue protection.

Glaucoma Surgery

OVDs assist in glaucoma surgeries by stabilizing anterior chambers and protecting ocular structures, supporting procedures such as trabeculectomy and minimally invasive glaucoma surgeries (MIGS).

Corneal Transplant

OVDs facilitate precise manipulation of donor and recipient corneal tissue, enhancing surgical outcomes and reducing postoperative complications.

Vitreoretinal Surgery

In vitreoretinal procedures, OVDs protect the retina and other delicate structures during manipulation, providing improved surgical control and patient safety.

Market Breakup by End Use

Hospitals

Hospitals are a significant end-user segment, offering comprehensive ophthalmic surgical services. OVDs are widely used in inpatient and outpatient surgical procedures, particularly in high-volume surgical centers.

Ophthalmic Clinics

Specialized ophthalmic clinics are increasingly adopting OVDs to perform routine and advanced eye surgeries efficiently. Clinics benefit from the reduced operating times and enhanced patient safety provided by these devices.

Others

Other end users include research institutions, eye care centers, and ambulatory surgical centers offering ophthalmic interventions and clinical trials.

Market Breakup by Region

North America

North America dominates the OVD market, driven by advanced healthcare infrastructure, high adoption of cataract and glaucoma surgeries, and strong investments in research and development.

Europe

Europe holds a significant share due to the aging population, well-established ophthalmic care systems, and increasing awareness about vision correction procedures.

Asia Pacific

Asia Pacific is expected to witness robust growth due to rising incidence of eye disorders, expanding surgical infrastructure, and increasing healthcare accessibility in countries such as India, China, and Japan.

Latin America

Latin America shows moderate growth, supported by improved healthcare access and adoption of modern ophthalmic surgical devices in urban centers.

Middle East and Africa

The market is emerging in these regions, fueled by rising investments in healthcare infrastructure, increasing eye care awareness, and expanding medical tourism.

Technological Trends Driving Market Growth

  • Advanced formulations: Development of cohesive and dispersive OVDs tailored for specific surgical applications.

  • Integration with phacoemulsification systems: Enhances precision, reduces operative time, and improves surgical outcomes.

  • Pre-filled and single-use OVDs: Promote sterility, reduce infection risk, and simplify surgical procedures.

  • Minimally invasive surgery support: OVDs facilitate MIGS, micro-incision cataract surgery, and vitreoretinal interventions.

These trends improve safety, efficiency, and patient outcomes, expanding the adoption of OVDs in ophthalmic care.

Competitive Landscape

The market is competitive, with key players focusing on product innovation, regional expansion, and strategic partnerships.

Companies covered include:

  • Bausch & Lomb, Inc.

  • Altacor Ltd.

  • Carl Zeiss Meditec AG

  • Rumex International Co.

  • Eyekon Medical Inc.

  • Bohus Biotech AB

  • Shanghai Haohai Biological Technology Co., Ltd.

  • Alcon Vision LLC

  • Others

These companies are actively investing in R&D, pre-filled device solutions, and regional market expansion to strengthen their global presence.

Challenges and Opportunities

Challenges

  • High cost of advanced OVDs in developing regions

  • Regulatory approvals and compliance requirements

  • Limited awareness of the benefits of specialized OVDs among some ophthalmic practitioners

Opportunities

  • Rising cataract and glaucoma surgeries in emerging markets

  • Growth of minimally invasive ophthalmic procedures

  • Development of single-use, pre-filled OVDs for improved convenience and safety

  • Expansion of ophthalmic surgical centers and clinics worldwide

Future Outlook

The Ophthalmic Viscoelastic Devices Market is projected to grow steadily through 2035. Increasing prevalence of age-related eye disorders, technological advancements, and growing adoption of minimally invasive surgical techniques will continue to drive demand. Enhanced formulations, pre-filled devices, and integration with modern ophthalmic surgical systems will improve patient outcomes, efficiency, and safety, positioning OVDs as essential tools in eye care globally.

Discover More Reports

Antimicrobial Hospital Curtains Market

Mastopexy Market

Gas Chromatography Market

Guidewires Market

About Us:

Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.

Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.

Media Contact:

Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: [email protected]
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com